Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
EV/Net Sales

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 4.265.094.7311.5010.84

What is the latest EV/Net Sales ratio of GLAND PHARMA ?

The latest EV/Net Sales ratio of GLAND PHARMA is 4.26 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20254.26
Mar20245.09
Mar20234.73
Mar202211.50
Mar202110.84

How is EV/Net Sales of GLAND PHARMA Trending?

Years EV/Net Sales % Change
Mar2025 4.26
-16.31
Mar2024 5.09
7.61
Mar2023 4.73
-58.87
Mar2022 11.5
6.09
Mar2021 10.84 -

Other Financial Ratios of GLAND PHARMA


Compare EV/Net Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹38,176.1 Cr 5.3% 0.3% 36.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,792.0 Cr 1.4% 1.2% 13.8% Stock Analytics
DIVIS LABORATORIES ₹178,152.0 Cr -0.5% -0.6% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,915.0 Cr 2.1% 1.5% 42.2% Stock Analytics
CIPLA ₹116,354.0 Cr 6.4% 1.6% -3.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,681.0 Cr 6.2% 1.6% 0.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

5.3%

0.3%

36.1%

SENSEX

-0.4%

0.8%

-5.3%


You may also like the below Video Courses